| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr13:96206600-96231000 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 2 |
chr13:96206800-96230200 |
Weak transcription |
H9 Cell Line |
embryonic stem cell
|
| 3 |
chr13:96208600-96230000 |
Weak transcription |
HUES64 Cell Line |
embryonic stem cell
|
| 4 |
chr13:96209200-96229000 |
Weak transcription |
HUES6 Cell Line |
embryonic stem cell
|
| 5 |
chr13:96210400-96229800 |
Weak transcription |
HUES48 Cell Line |
embryonic stem cell
|
| 6 |
chr13:96211000-96220600 |
Weak transcription |
Pancreas |
Pancrea
|
| 7 |
chr13:96212400-96231000 |
Weak transcription |
Fetal Kidney |
kidney
|
| 8 |
chr13:96213200-96220600 |
Weak transcription |
iPS-20b Cell Line |
embryonic stem cell
|
| 9 |
chr13:96216200-96217600 |
Enhancers |
HMEC |
breast
|
| 10 |
chr13:96216400-96217000 |
Enhancers |
Osteobl |
bone
|
| 11 |
chr13:96216400-96217200 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
| 12 |
chr13:96216400-96217200 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
| 13 |
chr13:96216600-96217000 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
| 14 |
chr13:96216600-96217000 |
Enhancers |
HUVEC |
blood vessel
|
| 15 |
chr13:96216600-96217200 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
| 16 |
chr13:96216600-96217600 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
| 17 |
chr13:96216600-96217600 |
Enhancers |
Hela-S3 |
cervix
|
| 18 |
chr13:96216600-96217800 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
| 19 |
chr13:96216800-96217000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 20 |
chr13:96216800-96217000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 21 |
chr13:96216800-96217200 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
| 22 |
chr13:96216800-96217200 |
Flanking Active TSS |
Primary monocytes fromperipheralblood |
blood
|
| 23 |
chr13:96216800-96217200 |
Enhancers |
NH-A |
brain
|
| 24 |
chr13:96216800-96217400 |
Flanking Active TSS |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
| 25 |
chr13:96216800-96217400 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
| 26 |
chr13:96216800-96217600 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
| 27 |
chr13:96216800-96217600 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
| 28 |
chr13:96216800-96217600 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
| 29 |
chr13:96216800-96217800 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
